Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02590367

Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

Huo JieGe, Doctor of Medicine,Professor of Medicine,Professor of Medical Science.

Sponsor: Jiangsu Province Hospital of Traditional Chinese Medicine

Interventions FOLFOX regimen HD6610 Granule HD6610 Granule placebo

Updated 7 times since 2017 Last updated: Nov 30, 2015 Started: Aug 31, 2015 Primary completion: Oct 31, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02590367, this PHASE2/PHASE3 trial focuses on Peripheral Neuropathy and remains ongoing. Sponsored by Jiangsu Province Hospital of Traditional Chinese Medicine, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Feb 2018 [monthly]

Recruiting PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu Province Hospital of Traditional Chinese Medicine

Data source: Jiangsu Province Hospital of Traditional Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China